Combination treatment modification methods and systems

• US 20090271009A1
• Filed: 06/13/2008
• Published: 10/29/2009
• Est. Priority Date: 04/24/2008
• Status: Abandoned Application

• Current Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Lord, Robert W., Levien, Royce A., Wood, Lowell L. JR., Hyde, Roderick A., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C.
• Application Number:
  US12/157,989
• Publication Number:
  US 20090271009A1
• Time in Patent Office: Days
• US Class Current: 700/28
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 20/60 relating to nutrition control, e.g. diets
• CPC Class Codes: G16H 20/70 relating to mental therapies, e.g. psychological therapy or autogenous training
• CPC Class Codes: G16H 70/60 relating to pathologies

Abstract

Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or modifying an artificial sensory experience to alter at least one effect of the bioactive agent.

Claims

1-64. -64. (canceled)

65. A system, comprising:

an acceptor module;

a modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent.

66. The system of claim 65, wherein the acceptor module comprises:

an acceptor module configured for accepting an identification of at least one medication prescribed for an individual.

67. The system of claim 66, wherein the acceptor module configured for accepting an identification of at least one medication prescribed for an individual comprises:

an acceptor module configured for accepting an identification of at least one of an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight-loss drug, an anti-Alzheimer'"'"'s medication, or an anti-stroke medication as the at least one medication.

68. The system of claim 65, wherein the acceptor module comprises:

an acceptor module configured for accepting an identification of an illicit substance used by an individual.

69. The system of claim 68, wherein the acceptor module configured for accepting an identification of an illicit substance used by an individual comprises:

an acceptor module configured for accepting an identification of at least one of alcohol use, psychoactive drug use, tranquilizer use, methamphetamine use, or narcotic use.

70. The system of claim 65, wherein the acceptor module comprises:

an acceptor module configured for accepting an identification of a nutraceutical used by an individual.

71. The system of claim 70, wherein the acceptor module configured for accepting an identification of a nutraceutical used by an individual comprises:

an acceptor module configured for accepting an identification of at least one of a memory supplement, an anti-oxidant, a cancer preventative, or a mood-changing agent.

72. The system of claim 65, wherein the acceptor module comprises:

an acceptor module configured for accepting at least one indication of bioactive agent use by at least one of a computer game participant, a social networking website participant, a virtual world participant, an online student, an online medical information user, or an on-line shopper.

73. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying access to at least a portion of the artificial sensory experience to alter at least one effect of the bioactive agent.

74. The system of claim 73, wherein the modifier module configured for modifying access to at least a portion of the artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a restrictor module configured for restricting access to at least a portion of the artificial sensory experience.

75. The system of claim 73, wherein the modifier module configured for modifying access to at least a portion of the artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a granter module configured for granting access to at least a portion of the artificial sensory experience.

76. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying a visual object in an artificial sensory experience to alter at least one effect of the bioactive agent.

77. The system of claim 76, wherein the modifier module configured for modifying a visual object in an artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a modifier module configured for modifying a color scheme of an artificial sensory experience to alter at least one effect of the bioactive agent.

78. The system of claim 76, wherein the modifier module configured for modifying a visual object in an artificial sensory experience to alter at least one effect of the bioactive agent comprises:

a modifier module configured for modifying at least a portion of text of an artificial sensory experience to alter at least one effect of the bioactive agent.

79. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

an alterer module configured for altering a sound in the artificial sensory experience.

80. The system of claim 79, wherein the alterer module configured for altering a sound in the artificial sensory experience comprises:

an alterer module configured for altering at least a portion of music in the artificial sensory experience.

81. The system of claim 79, wherein the alterer module configured for altering a sound in the artificial sensory experience comprises:

an alterer module configured for altering at least a portion of ambient noise in the artificial sensory experience.

82. The system of claim 79, wherein the alterer module configured for altering a sound in the artificial sensory experience comprises:

an alterer module configured for altering at least a portion of voice in the artificial sensory experience.

83. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying an artificial sensory experience to enhance efficacy of the bioactive agent.

84. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying an artificial sensory experience to reduce a side effect of the bioactive agent.

85. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

an adder module configured for adding at least one of visual or audio content to the artificial sensory experience.

86. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a deleter module configured for deleting at least one of visual or audio content of the artificial sensory experience.

87. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

an adder module configured for adding content to the artificial sensory experience and deleting different content of the artificial sensory experience.

88. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying a sensate experience to alter at least one effect of the bioactive agent.

89. The system of claim 88, wherein the modifier module configured for modifying a sensate experience to alter at least one effect of the bioactive agent comprises:

a modifier module configured for modifying at least one of an olfactory stimulus, a haptic stimulus, a visual stimulus, an auditory stimulus, or a taste stimulus to alter at least one effect of the bioactive agent.

90. The system of claim 65, wherein the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprises:

a modifier module configured for modifying an artificial sensory experience implemented on a mobile device.

91. The system of claim 65, wherein the acceptor module and the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprise:

an acceptor module configured for accepting an identification of at least one of a pain medication, an antianxiety medication, an anti-addiction medication, an eating disorder medication, an anti-obesity medication, or a mood-altering medication prescribed for an individual and modifying an artificial sensory experience to alter at least one effect of the bioactive agent.

92. The system of claim 65, wherein the acceptor module and the modifier module configured for modifying an artificial sensory experience to alter at least one effect of a bioactive agent comprise:

an acceptor module configured for accepting an identification of at least one anti-depressant medication prescribed for an individual and adding at least one cheerful attribute to a virtual world experience to enhance an anti-depressive effect of the anti-depressant medication.